1. Dr. Constantine Karakousis: The Quintessential Surgical Oncologist

   • Nicholas J. Petrelli
   • Charles Balch

   Sarcoma 08 October 2022 Pages: 7939 - 7941

   

2. Moving Forward with Omission of Breast Cancer Surgery Following Neoadjuvant Systemic Therapy

   • Henry M. Kuerer

   ASO Perspectives 24 August 2022 Pages: 7942 - 7944

3. Recognizing Disparities in Breast Cancer Patient-Reported Outcome Measures

   • Olga Kantor
   • Laura Dominici

   Breast Oncology 27 September 2022 Pages: 7945 - 7946

4. Supply and Demand: Is the Surgical Oncology Match in a Bear Market?

   • Dan G. Blazer III

   Global Health Services Research 14 September 2022 Pages: 7947 - 7949

5. Decreasing Medicare Reimbursements for Surgical Oncology Procedures: Future Implications

   • Mashaal Dhir
   • Thomas J. VanderMeer

   Global Health Services Research 05 October 2022 Pages: 7950 - 7952

6. Radiomics to the Rescue

   • Christopher W. Towe

   Thoracic Oncology 16 July 2022 Pages: 7953 - 7954

7. Soluble E-Cadherin as a Potential Biomarker in Hereditary Diffuse Gastric Cancer Syndrome

   • Martha E. Teke
   • Lauren A. Gamble
   • Jeremy L. Davis

   ASO Research Letter 26 July 2022 Pages: 7955 - 7957

   

8. Transgender and Non-binary Persons in Contemporary Oncology Randomized Clinical Trials

   • Enrique O. Martinez
   • Micah Rubin
   • Chandler S. Cortina

   ASO Research Letter 23 August 2022 Pages: 7958 - 7960

   

9. A Phase III, Randomized, Controlled Trial Comparing Open Versus Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma

   • Martha E. Teke
   • Areeba Saif
   • John J. Doski

   ASO Research Letter 09 September 2022 Pages: 7961 - 7963

   

10. Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, or Disease Stage?

    • Marissa K. Srour
    • Audree B. Tadros
    • Monica Morrow

    Breast Oncology 23 September 2022 Pages: 7964 - 7973

    

11. ASO Author Reflections: Engagement in Patient-Reported Outcomes for Breast Cancer

    • Marissa K. Srour
    • Audree B. Tadros
    • Monica Morrow

    ASO Author Reflections 04 September 2022 Pages: 7974 - 7974

12. ASO Visual Abstract: Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, and Disease Stage?

    • Marissa K. Srour
    • Audree B. Tadros
    • Monica Morrow

    ASO Visual Abstract 13 September 2022 Pages: 7975 - 7976

13. Disparities in Primary Breast Cancer Stage at Presentation Among Hispanic Subgroups

    • Nishwant Swami
    • Tiffany Nguyen
    • Fumiko Chino

    Breast Oncology 11 August 2022 Pages: 7977 - 7987

    

14. ASO Author Reflections: The Need for Disaggregated Study among Hispanic Populations

    • Nishwant Swami
    • Edward Christopher Dee
    • Fumiko Chino

    ASO Author Reflections 01 August 2022 Pages: 7988 - 7989

15. ASO Visual Abstract: Disparities in Primary-Stage Breast Cancer at Presentation Among Hispanic Subgroups

    • Nishwant Swami
    • Tiffany Nguyen
    • Fumiko Chino

    ASO Visual Abstract 06 August 2022 Pages: 7990 - 7991

16. Chyle Leak After Axillary Node Clearance in Breast Cancer Surgery—A Rare Complication and a Proposed Management Strategy from the British and Italian Experience

    • Arwa Ashoor
    • Germana Lissidini
    • Melissa Ley-Hui Tan

    Breast Oncology 18 July 2022 Pages: 7992 - 7999

    

17. ASO Author Reflections: Chyle Leak after Axillary Node Clearance in Breast Cancer Surgery, a Successful Management Approach from Leading Centres

    • Arwa Ashoor
    • Germana Lissidini
    • Melissa Ley-Hui Tan

    ASO Author Reflections 09 July 2022 Pages: 8000 - 8000

18. ASO Visual Abstract: Chyle Leak After Axillary Node Clearance in Breast Cancer Surgery: A Rare Complication and a Proposed Management Strategy from the British and Italian Experience

    • Arwa Ashoor
    • Germana Lissidini
    • Melissa Ley-Hui Tan

    ASO Visual Abstract 04 September 2022 Pages: 8001 - 8001

19. Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals?

    • Austin D. Williams
    • Chau T. Dang
    • Andrea V. Barrio

    Breast Oncology 24 July 2022 Pages: 8002 - 8011

    

20. ASO Author Reflections: Is It Worth the Risk? The Benefit of Neoadjuvant Chemotherapy in Elderly Patients with Breast Cancer

    • Austin D. Williams
    • Andrea V. Barrio

    ASO Author Reflections 08 August 2022 Pages: 8012 - 8013

21. ASO Visual Abstract: Neoadjuvant Chemotherapy for Breast Cancer in the Elderly—Are We Accomplishing Our Treatment Goals?

    • Austin D. Williams
    • Chau T. Dang
    • Andrea V. Barrio

    ASO Visual Abstract 28 July 2022 Pages: 8014 - 8015

22. Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx

    • Olga Kantor
    • Harold J. Burstein
    • Elizabeth A. Mittendorf

    Breast Oncology 27 July 2022 Pages: 8016 - 8023

    

23. ASO Visual Abstract: Expanding Staging Criteria in T1–2N0 Hormone Receptor-Positive Breast Cancer Patients Enrolled in TAILORx

    • Olga Kantor
    • Harold J. Burstein
    • Elizabeth A. Mittendorf

    ASO Visual Abstract 28 July 2022 Pages: 8024 - 8025

24. Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective Analysis

    • Yingbo Shao
    • Yang Yu
    • Hui Liu

    Breast Oncology 06 August 2022 Pages: 8026 - 8034

    

25. ASO Visual Abstract: Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting—A Retrospective Analysis

    • Yingbo Shao
    • Yang Yu
    • Hui Liu

    ASO Visual Abstract 16 August 2022 Pages: 8035 - 8036

26. Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy

    • Austin D. Williams
    • Atif J. Khan
    • Anita Mamtani

    Breast Oncology 11 August 2022 Pages: 8037 - 8043

    

27. ASO Author Reflections: Avoiding Overtreatment: Benefits of Selective Use of Frozen Sections Among cN0 Breast Cancer Patients Having Upfront Mastectomy

    • Austin D. Williams
    • Anita Mamtani

    ASO Author Reflections 16 August 2022 Pages: 8044 - 8045

28. ASO Visual Abstract: Omission of Intraoperative Frozen Section May Reduce Axillary Overtreatment Among Clinically Node-Negative Patients Having Upfront Mastectomy

    • Austin D. Williams
    • Atif J. Khan
    • Anita Mamtani

    ASO Visual Abstract 17 August 2022 Pages: 8046 - 8047

29. Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ

    • Megan E. Tesch
    • Shoshana M. Rosenberg
    • Ann H. Partridge

    Breast Oncology 12 August 2022 Pages: 8048 - 8057

30. ASO Visual Abstract: Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ

    • Megan E. Tesch
    • Shoshana M. Rosenberg
    • Ann H. Partridge

    ASO Visual Abstract 29 August 2022 Pages: 8058 - 8059

31. Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy

    • Erin A. Elder
    • Chad A. Livasy
    • Richard L. White Jr.

    Breast Oncology 18 August 2022 Pages: 8060 - 8069

    

32. ASO Author Reflections: Residual Cancer Burden Across Phenotypic Subtypes

    • E. Alexa Elder
    • Richard White

    ASO Author Reflections 04 August 2022 Pages: 8070 - 8070

33. ASO Visual Abstract: Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy

    • Erin A. Elder
    • Chad A. Livasy
    • Richard L. White Jr

    ASO Visual Abstract 04 September 2022 Pages: 8071 - 8071

34. Contemporary Trends in Breast Reconstruction Use and Impact on Survival Among Women with Inflammatory Breast Cancer

    • Ananya Gopika Nair
    • Vasily Giannakeas
    • David W. Lim

    Breast Oncology 08 September 2022 Pages: 8072 - 8082

    

35. ASO Visual Abstract: Contemporary Trends in Breast Reconstruction Use and Impact on Survival Amongst Women with Inflammatory Breast Cancer

    • Ananya Gopika Nair
    • Vasily Giannakeas
    • David W. Lim

    ASO Visual Abstract 07 September 2022 Pages: 8083 - 8083

36. Points to Consider Regarding De-Escalation Surgery in High-Risk Breast Cancer

    • Giovanni Corso
    • Francesca Magnoni
    • Paolo Veronesi

    Breast Oncology 15 September 2022 Pages: 8084 - 8089

    

37. ASO Author Reflections: Is Breast-Conserving Surgery a Safe Treatment Option for High-Risk Breast Cancer?

    • Francesca Magnoni
    • Giovanni Corso

    ASO Author Reflections 20 September 2022 Pages: 8090 - 8091

38. Breast Cancer Screening in Young Women with the Advent of Newer Techniques: Current Evidence and Future Considerations

    • Debdeep Saha
    • Akshay Balasubramanian
    • Sudharsanan Sundaramurthi

    Breast Oncology 08 October 2022 Pages: 8092 - 8093

39. Application and Match Rates in the Complex General Surgical Oncology Match

    • Jason Silvestre
    • Jessica R. Smith
    • Rachel R. Kelz

    Global Health Services Research 23 August 2022 Pages: 8094 - 8098

    

40. Trends in Reimbursement for Index Surgical Oncology Procedures in Contemporary Practice: Declining Reimbursement for Surgical Oncology Procedures—How Low Do We Go?

    • Thomas C. Hydrick
    • Jack Haglin
    • Nabil Wasif

    Global Health Services Research 29 September 2022 Pages: 8099 - 8106

    

41. Gender Disparities in Presentations at the Society of Surgical Oncology (SSO) Meetings From 2014 to 2019

    • Heather G. Lyu
    • Pamela Lu
    • Nancy L. Cho

    Global Health Services Research 12 July 2022 Pages: 8107 - 8114

    

42. ASO Visual Abstract: Gender Disparities in Presentations at the Society of Surgical Oncology (SSO) Meetings from 2014 to 2019

    • Heather G. Lyu
    • Pamela Lu
    • Nancy L. Cho

    ASO Visual Abstract 28 July 2022 Pages: 8115 - 8116

43. Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Using Routine Computed Tomography Imaging: Comparison of Size-Based Measurements and Radiomics-Based Models

    • Chenyi Xie
    • Yihuai Hu
    • Hong Yang

    Thoracic Oncology 26 August 2022 Pages: 8117 - 8126

    

44. ASO Author Reflections: Radiomics-Based Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma

    • Chenyi Xie
    • Yihuai Hu
    • Hong Yang

    ASO Author Reflections 06 August 2022 Pages: 8127 - 8128

45. ASO Visual Abstract: Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Using Routine CT Imaging: Comparison of Size-Based Measurements and Radiomics-Based Models

    • Chenyi Xie
    • Yihuai Hu
    • Hong Yang

    ASO Visual Abstract 06 September 2022 Pages: 8129 - 8130

46. Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer

    • Tsuyoshi Harada
    • Tetsuya Tsuji
    • Takeo Fujita

    Thoracic Oncology 17 August 2022 Pages: 8131 - 8139

    

47. ASO Author Reflections: Significance of Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy in Older Patients with Esophageal Cancer

    • Tsuyoshi Harada
    • Tetsuya Tsuji
    • Takeo Fujita

    ASO Author Reflections 17 August 2022 Pages: 8140 - 8141

48. ASO Visual Abstract: Prognostic Impact of the Loss of Skeletal Muscle Mass during Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer

    • Tsuyoshi Harada
    • Tetsuya Tsuji
    • Takeo Fujita

    ASO Visual Abstract 10 September 2022 Pages: 8142 - 8143

49. A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgically Resected Non-Small-Cell Lung Cancer Patients

    • Zihuai Wang
    • Zhenyu Yang
    • Lunxu Liu

    Thoracic Oncology 18 August 2022 Pages: 8144 - 8153

    

50. ASO Author Reflections: Comprehensive Comparison of N Staging Subclassification Methods for Non-Small-Cell Lung Cancer

    • Zhenyu Yang
    • Zihuai Wang
    • Lunxu Liu

    ASO Author Reflections 21 August 2022 Pages: 8154 - 8155